Next-Generation Antibody Therapeutics Market: Growth, Competitive Strategies and Worldwide Demand


Posted April 5, 2018 by psmarketresearch2017

Next-Generation Antibody Therapeutics Global Industry Analysis and Outlook - Including its Dynamics, Structure, Growth Factor, Top Key Player and Demand Drivers.

 
The global next-generation antibody therapeutics market is growing due to increasing popularity of antibody-drug conjugate (ADC) and increasing number of collaborations for R&D in next-generation antibody therapeutics. In addition, growing prevalence of chronic diseases and increase in research and development investments by various organizations for production of improved products further encourages the growth of global next-generation antibody therapeutics market. Furthermore, increase in healthcare expenditure and technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, which is resulting in increased demand for next-generation antibody therapeutics.

Explore report description with detailed TOC at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market

Based on technology, the Fc Engineered Antibodies market is expected to witness the highest growth (CAGR of 11%) during the forecast period. Among the therapeutic areas, the oncology segment led the global next-generation antibody therapeutics market in 2014, with the largest market size, but the autoimmune/inflammatory is expected to see the fastest growth of 46.4% CAGR, during the period 2015 – 2020.

Download Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample

However, certain restraints such as high cost of next-generation antibody therapeutics, stringent regulatory requirements and time-consuming approval process for new drugs are hindering the market growth. North America next-generation antibody therapeutics market is expected to witness the fastest growth of CAGR 46.2% globally, during the period 2015 – 2020.

Make Enquiry Before Buying this Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=next-generation-antibody-market

The key companies operating in the global next-generation antibody therapeutics market include Seattle Genetics Inc., F. Hoffmann-La Roche Ltd, ImmunoGen Inc., Pfizer Inc., Amgen Inc., Biogen, Kyowa Hakko Kirin Co. Ltd., Bristol-Myers Squibb Company, Xencor Inc., AstraZeneca PLC., Dyax Corp., Takeda Pharmaceuticals Company Limited and Bayer AG.


P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By PRAMOD
Country United States
Categories Health , News , Reports
Tags Next-Generation Antibody Therapeutics Market
Last Updated April 5, 2018